Word

KALYZEN

Status

Dead

Status Code

602

Status Date

Wednesday, May 23, 2018

Serial Number

87521660

Mark Type

4000

Filing Date

Monday, July 10, 2017

Abandoned Date

Monday, April 16, 2018

Trademark Owner History

Kalypso TC, LLC

Classifications

5 Medicinal infusions for treating depression, anxiety, and bipolar disorder

The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/01/2016
The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/01/2016
Concurrent use information. KalyZen is a combination of multiple drugs used in a single formulation and administered as a long-term infusion of ketamine for depression and bipolar disorder. This name has been used by Kalypso Wellness Centers since January of 2016.
"KALYZEN"
The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
KALY ZEN
The non-Latin characters in the mark transliterate to KalyZen and this means KalyZen in English. The non-Latin characters in the mark transliterate to KalyZen and this has no meaning in a foreign language.
The English translation of KalyZen in the mark is KalyZen. The wording KalyMax has no meaning in a foreign language.

Trademark Events

May 23, 2018

Abandonment Notice Mailed - Failure To Respond

May 23, 2018

Abandonment - Failure To Respond Or Late Response

Oct 13, 2017

Notification Of Non-Final Action E-Mailed

Oct 13, 2017

Non-Final Action E-Mailed

Oct 13, 2017

Non-Final Action Written

Oct 5, 2017

Assigned To Examiner

Jul 15, 2017

New Application Office Supplied Data Entered In Tram

Jul 13, 2017

New Application Entered In Tram